{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreici2zt343b6ni6ksfc7vwgypalhou5vzut7ntrd2bk4wj2pymid2e",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjxltap2eos2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibxl7qf2ecikjhpvis3rf7g5huuun72647sza6rwfx5qluwqu5khy"
    },
    "mimeType": "image/jpeg",
    "size": 417828
  },
  "path": "/news/2026-04-antibiotics-neonatal-sepsis-infections-middle.html",
  "publishedAt": "2026-04-20T18:10:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A major multi-country study has found that WHO-recommended first-line antibiotics for neonatal sepsis are likely to be effective in only one-quarter of infections in low- and middle-income countries (LMICs). The findings, presented today at ESCMID Global 2026 in Munich, highlight the growing impact of antimicrobial resistance (AMR).",
  "title": "WHO-recommended antibiotics cover only 1 in 4 neonatal sepsis infections in low- and middle-income countries"
}